Zobrazeno 1 - 10
of 90
pro vyhledávání: '"P Pabot du Chatelard"'
Autor:
Raymonde Bouvier, V. Ravery, M. Peneau, N Berger, E Fontaine, Jean-Léon Lagrange, D Rossi, Jean-Yves Soret, J.M. Bachaud, D Prapotnitch, A Villers, D Brune, Vincent Molinié, A Daver, B Guilloneau, A Bataillard, Pierre Richaud, Béatrice Fervers, A F Bertrand, J P Muratet, P Pabot du Chatelard, O Haillot, P. Pommier
Publikováno v:
Cancer/Radiothérapie. 5:770-786
Contexte. - La Federation nationale des centres de lutte contre le cancer (FNCLCC) et les Centres regionaux de lutte contre le cancer (CRLCC), en collaboration avec des partenaires des secteurs public (CHU, CHG), prive et certaines societes savantes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee73152a361c8ebc12c7d387394509cf
https://doi.org/10.1016/s1278-3218(01)00138-x
https://doi.org/10.1016/s1278-3218(01)00138-x
Autor:
A Daver, P Pabot du Chatelard
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 8:228-233
Resume Le pronostic des tumeurs germinales testiculaires non seminome pur (TGNS) s'est considerablement ameliore ces 15 dernieres annees grâce au traitement medical efficace. Le seminome pur, lui, reste bien controle. Afin de situer l'interet cliniq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58e598e4eef976e1b121e2c39d2528bd
https://doi.org/10.1016/s0923-2532(05)80005-5
https://doi.org/10.1016/s0923-2532(05)80005-5
Publikováno v:
Presse medicale (Paris, France : 1983). 32
FEWER INDICATIONS AFTER SPLENECTOMY: Real therapeutic progress has been achieved over the last fifty years for patients with Hodgkin's disease known for their chronic immunodepression. Since the advent of effective chemotherapy protocols such as ABVD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f0c15190c9dabd94028b22d79b197d1
https://pubmed.ncbi.nlm.nih.gov/14631638
https://pubmed.ncbi.nlm.nih.gov/14631638
Autor:
P, Pommier, A, Villers, A, Bataillard, D, Brune, B, Fervers, J M, Bachaud, N, Berger, A F, Bertrand, R, Bouvier, A, Daver, E, Fontaine, O, Haillot, J L, Lagrange, V, Molinié, J P, Muratet, P, Pabot du Chatelard, M, Peneau, D, Prapotnitch, V, Ravery, P, Richaud, D, Rossi, M, Soulié
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 6(2)
The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::437416044e7c0569fedb84ff7cda355f
https://pubmed.ncbi.nlm.nih.gov/12035484
https://pubmed.ncbi.nlm.nih.gov/12035484
Autor:
P, Pommier, A, Villers, A, Bataillard, D, Brune, B, Fervers, J M, Bachaud, N, Berger, A F, Bertrand, R, Bouvier, A, Daver, E, Fontaine, B, Guilloneau, O, Haillot, J L, Lagrange, V, Molinié, J P, Muratet, P, Pabot du Chatelard, M, Peneau, D, Prapotnitch, V, Ravery, P, Richaud, D, Rossi, J Y, Soret
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 5(6)
The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ccf6406bda8b39c7c5d74c216f9da58
https://pubmed.ncbi.nlm.nih.gov/11797299
https://pubmed.ncbi.nlm.nih.gov/11797299
Publikováno v:
Annales d'urologie. 31(2)
A 30-year-old man with a testicular tumor ressembling a "round cell sarcoma" was treated for rhabdomyosarcoma. Complete remission was achieved but the patient relapsed and died of the disease. A retrospective diagnosis of granulocytic sarcoma was est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20e49124ca6bc42028e0b77f8e6ad9de
https://pubmed.ncbi.nlm.nih.gov/9245249
https://pubmed.ncbi.nlm.nih.gov/9245249
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 4(4)
The authors report a case of pure small cell carcinoma of the prostate expressing neuroendocrine markers on immunohistochemistry. Treatment consisted of chemotherapy with cisplatin and etoposide combined with regional external beam radiotherapy. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52f379ea05dbd3a3940d7a4ddfacb021
https://pubmed.ncbi.nlm.nih.gov/7920732
https://pubmed.ncbi.nlm.nih.gov/7920732
Autor:
P, Pabot du Chatelard, J, Merrer
Publikováno v:
Annales d'urologie. 26(2)
There are two other treatments for germ cell tumours of the testis apart from surgery: radiotherapy and chemotherapy. Radiotherapy is ideally administered with a linear accelerator delivering photons and electrons. The dose is well established and sm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d37aaf44de6826a011756fc149847881
https://pubmed.ncbi.nlm.nih.gov/1616299
https://pubmed.ncbi.nlm.nih.gov/1616299
Publikováno v:
Annales d'urologie. 26(2)
In 1992, the staging and follow-up of testicular germ cell tumours is based on a combination of computed tomography and tumour markers. Due to the development of medical imaging over the last decade, abdominal and thoracic CT has now replaced the com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de83f76d14e11d9e3b0141ca61917403
https://pubmed.ncbi.nlm.nih.gov/1377462
https://pubmed.ncbi.nlm.nih.gov/1377462
Publikováno v:
Annales d'urologie. 26(2)
The therapeutic indications for germ cell tumours of the testis depend on the histology (pure seminoma: 45%, non-seminomatous germ cell tumour: 55%), the extension and the severity of the prognosis. The well standardised approach to pure seminomas is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02f8e3cb6265d9fb72cd9b35e96c4d34
https://pubmed.ncbi.nlm.nih.gov/1616300
https://pubmed.ncbi.nlm.nih.gov/1616300